{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T19:46:39Z","timestamp":1648842399935},"reference-count":7,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.cancergencyto.2010.09.011","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T10:25:04Z","timestamp":1292322304000},"page":"355-356","source":"Crossref","is-referenced-by-count":1,"title":["Letter to the Editor regarding the article \u201cChromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenic and prognostic implications\u201d"],"prefix":"10.1016","volume":"203","author":[{"given":"Vesna","family":"Najfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2010.09.011_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cancergencyto.2010.02.003","article-title":"Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implications","volume":"199","author":"Zaccaria","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.09.011_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0002-9343(77)90124-3","article-title":"Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte\/macrophage","volume":"63","author":"Fialkow","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.cancergencyto.2010.09.011_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1182\/blood.V58.1.158.158","article-title":"Evidence for a multistep pathogenesis of chronic myelogenous leukemia","volume":"58","author":"Fialkow","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.09.011_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/287049a0","article-title":"Involvement of the B-lymphoid system in chronic myelogenous leukaemia","volume":"287","author":"Martin","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2010.09.011_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0165-4608(82)90092-9","article-title":"B-lymphoid cell involvement in chronic myelogenous leukemia: implications for the pathogenesis of the disease","volume":"6","author":"Martin","year":"1982","journal-title":"Cancer Genetics Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.09.011_bib6","first-page":"1163","article-title":"Further evidence for the existence of a clonal Ph-negative stage in some cases of Ph-positive chronic myelocytic leukemia","volume":"7","author":"Raskind","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.09.011_bib7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0301-472X(03)00176-0","article-title":"The emergence of Ph-, trisomy -8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylate","volume":"31","author":"Feldman","year":"2003","journal-title":"Exp Hematol"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810005017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810005017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T16:43:42Z","timestamp":1592153022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460810005017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0165460810005017"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.09.011","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}